Finally, the gene expression patterns of cancer cell lines from the Genomics of Drug Sensitivity in Cancer database were combined in order to comprehensively investigate the potential therapeutic benefit of the EIF4A1, EIF4G4, NCBP1, and WDR4 genes. This evidence concerns the gene NCBP1 and cancer.